ArticleCureus2025

Luseogliflozin Persistently Lowers Glycemia and Body Weight Over a Period of Two Years in Patients With Type 2 Diabetes.

Jun-Ichirou Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.